The emerging treatment of the medication represents a exciting development in the care of type 2 diabetes. Unlike existing drugs, tirzepatide impacts dual pathways – the GLP-1 hormone and the GIP hormone – leading https://tirzepatidepeptide797370.smblogsites.com/42105376/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment